Hearnden Vanessa, MacNeil Sheila, Battaglia Giuseppe
Department of Materials Science and Engineering, Kroto Research Institute, University of Sheffield, Sheffield, UK.
Methods Mol Biol. 2011;695:41-51. doi: 10.1007/978-1-60761-984-0_3.
Here we describe a method for imaging the position of nanoparticles within a 3D tissue-engineered model using confocal laser scanning microscopy (CLSM). The ability to track diffusion of nanoparticles in vitro is an important part of trans-dermal and trans-mucosal drug delivery development as well as for intra-epithelial drug delivery. Using 3D tissue-engineered models enables us to image diffusion in vitro in a physiologically relevant way; not possible in two-dimensional monolayer cultures (MacNeil, Nature 445:874-880, 2007; Hearnden et al., Pharmaceutical Res. 26(7):1718-1728, 2009). CLSM enables imaging of viable in vitro models in three dimensions with good spatial and axial resolution (Georgakoudi et al., Tissue Eng 14:1-20, 2008; Schenke-Layland et al., Adv. Drug Del. Rev. 58:878-896, 2006). Here we show that fluorescently labelled nanoparticles can be visualised, quantified, and their position within the cell can be determined using CLSM.
在此,我们描述了一种使用共聚焦激光扫描显微镜(CLSM)对三维组织工程模型内纳米颗粒位置进行成像的方法。在体外追踪纳米颗粒的扩散能力是经皮和经粘膜药物递送研发以及上皮内药物递送的重要组成部分。使用三维组织工程模型使我们能够以生理相关的方式对体外扩散进行成像;这在二维单层培养中是不可能的(麦克尼尔,《自然》445:874 - 880,2007;赫恩登等人,《药物研究》26(7):1718 - 1728,2009)。CLSM能够以良好的空间和轴向分辨率对体外活细胞模型进行三维成像(乔治亚库迪等人,《组织工程》14:1 - 20,2008;申克 - 莱兰德等人,《药物递送进展评论》58:878 - 896,2006)。在此我们表明,使用CLSM可以对荧光标记的纳米颗粒进行可视化、定量,并确定其在细胞内的位置。